Middletown, DE -- (SBWIRE) -- 10/03/2013 -- VipStockReports.com screens the markets looking for Hot Emerging Micro-cap and Small cap stocks that look to Run High. Our team STRONGLY believes the penny stock market can powerfully reward average traders, and we are here to lead the way. Today our focus is on: Huntington Bancshares Incorporated (NASDAQ:HBAN), Frontier Communications Corp (NASDAQ:FTR), Astex Pharmaceuticals, Inc.(NASDAQ:ASTX), Achillion Pharmaceuticals, Inc.(NASDAQ:ACHN)
Huntington Bancshares Incorporated (NASDAQ:HBAN) opened the session at $8.30, remained amid the day range of $8.26 - $8.38, and closed the session at $8.35. The stock showed a negative performance of -0.06% in previous trading session. The stock gained a volume of 8.63 million shares and the average volume of the stock remained 9.65 million shares. Huntington Bancshares Incorporated operates as the holding company for The Huntington National Bank that provides commercial, small business, and consumer banking services. The company also offers online, mobile, and telephone banking; and brokerage and wealth management services.
Will HBAN Get Buyers Even After The Recent Rally? Find Out Here
Frontier Communications Corp (NASDAQ:FTR) traded with volume of 8.27 million shares in the prior session and the average volume of the stock remained 8.39 million shares. The 52 week range of the stock remained $3.71 - $4.95. The stock showed a positive movement of +0.82% and closed its session at $4.29. The market capitalization of the stock remained 4.29 billion. Frontier Communications Corporation, a communications company, provides regulated and unregulated voice, data, and video services to business, residential, and wholesale customers in the United States. The company offers local and long distance voice services, including basic telephone wireline services to residential and business customers; and packages of communications services.
Will FTR Continue To Move Higher? Find Out Here
Astex Pharmaceuticals, Inc.(NASDAQ:ASTX) exchanged 7.96 million shares and the average volume remained 5.11 million shares. The stock escalated +1.53% and closed the session at $8.63. The beta of the stock remained 1.07 and the EPS of the stock remained -0.01. Astex Pharmaceuticals, Inc. engages in the discovery and development of small molecule therapeutics with a focus on oncology and hematology using its fragment-based drug discovery platform, Pyramid. The company offers Dacogen (decitabine) for injection for the treatment of patients with myelodysplastic syndrome (MDS). It was formerly known as SuperGen, Inc. and changed its name to Astex Pharmaceuticals, Inc. in September 2011.
For How Long ASTX will fight for Profitability? Read This Trend Analysis report
Achillion Pharmaceuticals, Inc.(NASDAQ:ACHN) gained volume of 7.44 million shares, while the average volume remained 2.91 million shares. The stock advanced +8.68% and finished the session Wednesday at $2.88. The EPS of the stock remained -0.68. The one month of the stock was -55.35% and three month trend remained negative -53.99%. Achillion Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes anti-infective drug therapies in the United States and internationally. It focuses on the development of antivirals for the treatment of chronic hepatitis C viral (HCV) infection. The company was founded in 1998 and is headquartered in New Haven, Connecticut.
For How Long ACHN’s Gloss will Attract Investors? Find out via this report
We screen the markets looking for Hot Emerging Micro-cap and Small cap stocks that look to Run High. Once we find the 'Next Hot Penny Stock' with Monster Upside Potential we immediately Email it to you in our detailed VIP Report so you can Beat Rest of the Crowd!!
Our team STRONGLY believes the penny stock market can powerfully reward average traders, and we are here to lead the way.
VipstockReports.com newsletters and website: The disclaimer is to be read entirely and fully understood before using our website, or joining our newsletter email list. Never invest into a stock discussed on this website or the Vipstockalerts.com newsletter unless you can afford to lose your entire investment. Please consult with a certified financial advisor before making any investment decisions.
VipStockReports.com and any affiliates and information providers make no implied or express warranties on the information provided. Please verify quotes with your financial advisor before making investment decisions. This is not to be construed as a solicitation to buy or sell securities. As with any stock, the featured companies profiled on the VipstockReports.com web site and/or newsletter involve a high degree of volatility and risk, and all investors should know that they may lose a portion of or all of their investment if they decide to purchase any stocks.
Read Full Disclaimer at: http://www.vipstockreports.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)